
Plant-based nanoparticles successfully treat inflammatory bowel disease in animal model.
There is a clinical need for new, more effective treatments for chronic and debilitating inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. Now, a study from researchers at the VA and the Georgia State University characterizes a specific population of nanoparticles derived from edible ginger (GDNPs 2) and demonstrates their efficient colon targeting following oral administration. The team state that their ginger nanoparticles, … Continue reading Plant-based nanoparticles successfully treat inflammatory bowel disease in animal model.